SCHEMBL24815798

SCHEMBL24815798

COC(=O)c1ccc2c(c1)CN(C(=O)CS(=O)(=O)c1nccs1)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 7/20 0.42
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ ACACB O00763 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ PPARG P37231 1/20 0.35
▸ MAPK10 P53779 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ NCOR2 Q9Y618 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ DHFR P00374 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29987611 1.00 NAMPT (0.42) NAMPTHDAC8HDAC6TP53ACACB
SCHEMBL24814391 0.86 RYR2 (0.43) NAMPTTP53ALDH1A1SMN1; SMN2RAB9A
SCHEMBL26845908 0.84 DPP8 (0.40) NAMPTTP53ALDH1A1KMT2ASMN1; SMN2
SCHEMBL29987551 0.83 MAOB (0.39) NAMPTSMN1; SMN2
SCHEMBL24817127 0.82 MAOB (0.40) NAMPTHDAC8ALDH1A1KMT2ASMN1; SMN2
SCHEMBL24817122 0.82 NAMPT (0.44) NAMPT
SCHEMBL29986905 0.81 SMN1; SMN2 (0.42) NAMPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL24815669 0.81 SMN1; SMN2 (0.42) NAMPTALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL24815670 0.79 NLRP3 (0.35) ALDH1A1KMT2ASMN1; SMN2MAPK1NPC1
SCHEMBL24814740 0.79 NLRP3 (0.35) NAMPTSMN1; SMN2RAB9ANPC1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH NAMPT 2850/4885HDAC8 2213/4885HDAC6 1820/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH NAMPT 2850/4885HDAC8 2213/4885HDAC6 1820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback